| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > Prevention Of Malaria On The Way? |
|
Advice Pool - Prevention Of Malaria On The Way?
All around the world, malaria can be a very serious problem.-especially in According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product areas where mosquitoes are plentiful, since they are one of the main source ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s of passing the disease on. An estimated 700,000 people die each year from lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. the debilitating disease, so this is at the utmost urgency. We have all wi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe nessed the distressing images of impoverished people in malaria-ridden land d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s dying of the disease. Researchers have recently genetically engineered a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc new kind of mosquito- one completed resistant to the malaria. The test con easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ucted forced mosquitoes to feed on malaria-infected mice. Some of the mosqu nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically itoes were resistant, and those were saved. The mosquitoes that contracted and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the malaria were thrown out of the experiment. From this singling out, scie ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tists could study and genetically alter/breed new mosquitoes that were resi ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a stant to the disease. The tests are relatively safe- don’t worry. The same dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod malaria that infects mice does not infect humans. For this reason, no big cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin leap and bounds have been made just yet. The scientists have begun work on tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen reeding mosquitoes to not transmit the human form of malaria- something tha t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel t will take time. But the end point could represent a huge sea change in th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e pattern and spread of the disease. The tests are funded by the National y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nstitutes of Health. The successes so far are showing some promising result . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s, but nothing can be used as of yet to benefit mankind. The research has e elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip xpected to one day block the illness, but for now we can only wait and hope tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Career Advice: Stop Feeling Guilty About Time Off! Does Your Marriage Suffer from an Attention Shortage?
|